Shi Qiang, Zhong Yun-shi, Yao Li-qing, Zhou Ping-hong, Xu Mei-dong, Chen Shi-yao
Fudan University, Shanghai, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jul;15(7):675-8.
To assess the clinical value of endoscopic submucosal dissection(ESD) for duodenal lesion.
A total of 78 patients with duodenal lesion were treated with ESD from November 2006 to August 2010. The clinical data were retrospectively analyzed.
There were 46 male and 14 female patients. The mean age was(54±9) years. The lesion location included the duodenal bulb(n=39, 50%), the junction of bulb and descending part(n=19, 24.4%), and the descending part(n=20, 25.8%). The mean diameter of the lesions was(2.1±1.7) cm. Fifty-one(65.4%) lesions originated from the mucosa, including inflammatory/ hyperplastic polyps(n=22, 28.2%), villous/tubular adenoma(n=26, 33.3%), and hamartomas polyps(n=3, 3.8%). Twenty-five(32.1%) lesions originated from the submucosa, including Brunner's glands adenoma(n=15, 19.2%), ectopic pancreas(n=3, 3.8%), carcinoid tumor(n=3, 3.8%), lipoma(n=2, 2.6%), myxoinoma(n=1, 1.3%), and angio-lymphangioma(n=1, 1.3%). There were two lesions originated from the muscularis propria(n=2, 2.5%), and both were ectopic pancreas. All cases received ESD successfully. The mean operative time was(37±41) min and the mean blood loss was(23±15) ml. The perioperative complication rate was 35.9%(28/78), including intraoperative perforation(n=6), delayed perforation(n=3), intraoperative hemorrhage(n=10), delayed bleeding(n=7), and transient elevation of serum amylase(n=2). Postoperative pathological examination showed vascular invasion with tumor cells in one patient, who received extended resection later. The remaining 77 patients showed no recurrence during the followed up(rang, 3-23 months) using endoscopy.
ESD is an effective, safe, minimally invasive method for the management of duodenal lesions.
评估内镜黏膜下剥离术(ESD)治疗十二指肠病变的临床价值。
回顾性分析2006年11月至2010年8月期间接受ESD治疗的78例十二指肠病变患者的临床资料。
男性46例,女性14例。平均年龄(54±9)岁。病变部位包括十二指肠球部(39例,50%)、球部与降部交界处(19例,24.4%)、降部(20例,25.8%)。病变平均直径(2.1±1.7)cm。51例(65.4%)病变起源于黏膜,包括炎性/增生性息肉(22例,28.2%)、绒毛状/管状腺瘤(26例,33.3%)、错构瘤性息肉(3例,3.8%)。25例(32.1%)病变起源于黏膜下层,包括Brunner腺腺瘤(15例,19.2%)、异位胰腺(3例,3.8%)、类癌肿瘤(3例,3.8%)、脂肪瘤(2例,2.6%)、黏液瘤(1例,1.3%)、血管淋巴管瘤(1例,1.3%)。2例病变起源于固有肌层(2例,2.5%),均为异位胰腺。所有病例ESD均成功。平均手术时间(37±41)分钟,平均出血量(23±15)ml。围手术期并发症发生率为35.9%(28/78),包括术中穿孔(6例)、延迟穿孔(3例)、术中出血(10例)、延迟出血(7例)、血清淀粉酶短暂升高(2例)。术后病理检查显示1例患者肿瘤细胞侵犯血管,该患者随后接受了扩大切除术。其余77例患者随访(3 - 23个月)期间经内镜检查无复发。
ESD是治疗十二指肠病变的一种有效、安全、微创的方法。